MB
Healthcare & Life Sciences
Magnet Biomedicine
United Statesmagnetbio.com/
Magnet Biomedicine is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 1 tracked investor.
Activeseries-c-plus
series-c-plus
Stage
1
Investors
About Magnet Biomedicine
Magnet Biomedicine is a company headquartered in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Magnet Biomedicine develops orally administered molecular glue inhibitors using its proprietary TrueGlue™ platform to discover precision medicines targeting hard-to-drug proteins for immune disorders and cancer.
Explore Magnet Biomedicine's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.